Age at disease onset: a key factor for understanding psoriatic disease
about
HLA-B27 and psoriatic disease: a modern view of an old relationshipModelling epidermis homoeostasis and psoriasis pathogenesis.The psychosocial impact of acne, vitiligo, and psoriasis: a reviewThe Challenge of Managing Psoriasis: Unmet Medical Needs and Stakeholder Perspectives.Large scale meta-analysis characterizes genetic architecture for common psoriasis associated variants.The Neurobehavioral Phenotype in Mucopolysaccharidosis Type IIIB: an Exploratory Study.Gender differences among patients with primary ankylosing spondylitis and spondylitis associated with psoriasis and inflammatory bowel disease in an iberoamerican spondyloarthritis cohort.Characteristics of Turkish patients with elderly onset psoriatic arthritis: A retrospective cohort study.Disease activity in and quality of life of patients with psoriatic arthritis mutilans: the Nordic PAM Study.Therapy of psoriasis with narrowband ultraviolet-B light influences plasma concentrations of MMP-2 and TIMP-2 in patients.Influence of narrowband ultraviolet-B phototherapy on plasma concentration of matrix metalloproteinase-12 in psoriatic patients.Correlation analysis of the HLA-DPB1*05:01 and BTNL2 genes within the histocompatibility complex region with a clinical phenotype of psoriasis vulgaris in the Chinese Han population.HLA-C*06:02-independent, gender-related association of PSORS1C3 and PSORS1C1/CDSN single-nucleotide polymorphisms with risk and severity of psoriasis.Multidisciplinary care for psoriatic disease: Where we are and where we need to go.
P2860
Q26796433-ACB73991-8D53-409D-9CE7-857945A1B64DQ27346151-1AB7838F-8177-45D2-B815-FD6308676BDBQ28066163-54175794-D203-45B2-94D0-5809EFF2BDCFQ33572834-8B4306A9-97E6-4651-AA8C-1A04E953F67EQ33761227-2C6DCDAE-2013-4342-B689-F2AE5C5CA82EQ36602806-DBF0EBC7-8C33-4646-8FA1-99C702998216Q37530561-8D4D1BA8-4363-454A-BCA4-202E9C88130DQ38620289-C8AE527F-958A-489C-8F25-7F2086130028Q38918484-E2504CB4-A74A-45AD-8850-E462BC7BCBB6Q41610884-AB49C14B-20F0-4093-93A9-5003912B95FBQ41690217-34699EC0-5AD1-4886-874B-4872052D165CQ50601691-7A2A3950-A15C-4B7F-BE3D-707659500D3AQ52339737-974A1DB9-7C4F-4FC1-9D8A-991B5472B527Q53734674-7B3E83D6-9B6B-48D1-A3BE-E119D2FF6E9F
P2860
Age at disease onset: a key factor for understanding psoriatic disease
description
2014 nî lūn-bûn
@nan
2014 թուականի Յուլիսին հրատարակուած գիտական յօդուած
@hyw
2014 թվականի հուլիսին հրատարակված գիտական հոդված
@hy
2014年の論文
@ja
2014年学术文章
@wuu
2014年学术文章
@zh-cn
2014年学术文章
@zh-hans
2014年学术文章
@zh-my
2014年学术文章
@zh-sg
2014年學術文章
@yue
name
Age at disease onset: a key factor for understanding psoriatic disease
@ast
Age at disease onset: a key factor for understanding psoriatic disease
@en
Age at disease onset: a key factor for understanding psoriatic disease
@nl
type
label
Age at disease onset: a key factor for understanding psoriatic disease
@ast
Age at disease onset: a key factor for understanding psoriatic disease
@en
Age at disease onset: a key factor for understanding psoriatic disease
@nl
prefLabel
Age at disease onset: a key factor for understanding psoriatic disease
@ast
Age at disease onset: a key factor for understanding psoriatic disease
@en
Age at disease onset: a key factor for understanding psoriatic disease
@nl
P2093
P2860
P3181
P356
P1433
P1476
Age at disease onset: a key factor for understanding psoriatic disease
@en
P2093
Pablo Coto
Patricia Tejón
Sara Alonso
P2860
P304
P3181
P356
10.1093/RHEUMATOLOGY/KET363
P407
P50
P577
2013-11-22T00:00:00Z